공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 환자 참여 솔루션 시장 : 제공 형태, 구성요소(소프트웨어, 서비스), 기타 최종 용도, 애플리케이션. 치료 영역, 지역별 시장 규모, 시장 점유율 및 동향 분석, 부문별 예측(2021-2028년)

Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Delivery Type, By Component (Software, Services), By End-use, By Application, By Therapeutic Area, By Region, And Segment Forecasts, 2021 - 2028

리서치사 Grand View Research, Inc.
발행일 2021년 02월 상품 코드 995274
페이지 정보 영문 120 Pages
가격
US $ 5,950 ₩ 6,869,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,023,000 Printable PDF (5-User License)
US $ 8,950 ₩ 10,332,000 Printable PDF (Enterprise License)


세계의 환자 참여 솔루션 시장 : 제공 형태, 구성요소(소프트웨어, 서비스), 기타 최종 용도, 애플리케이션. 치료 영역, 지역별 시장 규모, 시장 점유율 및 동향 분석, 부문별 예측(2021-2028년) Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Delivery Type, By Component (Software, Services), By End-use, By Application, By Therapeutic Area, By Region, And Segment Forecasts, 2021 - 2028
발행일 : 2021년 02월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 환자 참여 솔루션 시장 규모는 2021년부터 2028년까지 21.4%의 CAGR로 확대되어 2028년 705억 달러에 달할 것으로 예상됩니다.

m-health의 채용, 당뇨병, 천식, 관절염 등 만성 질환의 발병률 증가, 의료 서비스 개선, 환자 교육 향상, 환자 데이터 추적 및 진단 치료 등으로 시장은 기하급수적으로 성장을 기록할 전망입니다.

2021년 1월 바이든 해리스 정권은 특별 환자 참여 솔류션 가입 기간을 마련했습니다. 이 법적 조치에 따라 미국인은 건강보험에 가입할 때 메디케이드 의료비 부담이 줄어들며 건강 관리 서비스 혜택을 받게 됩니다. 이러한 행정 명령에 따라 COVID-19 발생으로 형성된 의료 요구 사항을 충족하며, 건강 서비스 의료 이용을 보호하고 의료 제도가 개선될 전망입니다. 이러한 정부 사업은 예측 기간 동안 서비스 수요를 촉진할 것으로 예상됩니다.

세계의 환자 참여 솔루션(Patient Engagement Solutions) 시장을 조사 분석했으며, 시장 및 산업 전망, 부문·지역별 전망 외에도 경쟁 상황에 대한 체계적인 정보를 제공합니다.

목차

제1장 조사 방법 및 범위

  • 시장 세분화 및 범위
  • 조사 방법
  • 정보 취득
  • 정보 또는 데이터 분석
  • 시장 수립 및 검증
  • 모델에 대한 자세한 설명
  • 2차 자료 목록
  • 1차 자료 목록
  • 약어
  • 목적

제2장 개요

제3장 환자 참여 솔루션 시장 변수의 동향과 범위

  • 시장 계통의 전망
  • 기술별 보급과 성장 전망 매핑(2020년)
  • 사용자 관점 분석
  • 규제 프레임워크
  • 기술 개요
  • 시장 역학
  • 산업 분석 - 포터의 5세력 모형
  • 환자 참여 솔루션 - 요인별 SWOT 분석(정치와 법, 경제, 사회와 기술)
  • 주요 거래와 전략 제휴 분석
  • 시장 진입 전략

제4장 환자 참여 솔루션 시장 : 경쟁 분석

  • 시장 참여자 분류
  • 벤더 정세
    • 주요 유통 업체와 채널 파트너 목록
  • 주요 기업의 시장 점유율 분석(2020년)
  • 공개 기업
    • 기업 시황 분석(수익, 지리적 입지, 제품 포트폴리오, 서비스 가능한 업계 주요 협력)
    • 시장 차별화
    • 시너지 효과 분석 : 주요 거래와 전략적 제휴
  • 비공개 기업
    • 주요 신흥 기업/기술 디스럽터/혁신 기업 리스트
    • 지역 네트워크 맵
  • 주요 고객
    • 주요 구매자 목록
  • 잠재 타겟 고객

제5장 환자 참여 솔루션 시장 : 제공 형태별

  • 제공 형태별 시장 분석

제6장 환자 참여 솔루션 시장 : 구성요소별

  • 구성요소별 시장 분석

제7장 환자 참여 솔루션 시장 : 최종 용도별

  • 최종 용도별 시장 분석

제8장 환자 참여 솔루션 시장 : 애플리케이션별

  • 애플리케이션별 시장 분석

제9장 환자 참여 솔루션 시장 : 치료 영역별

  • 치료 영역별 시장 분석

제10장 환자 참여 솔루션 : 지역 시장 분석(애플리케이션, 기술 및 최종 용도별), 2016-2028년, 백만 달러

  • 지역별 시장 점유율 분석(2020-2028년)
  • 지역별 시장 대시보드
  • 지역별 시장 스냅
  • 시장 규모 및 예측, 동향 분석(2020-2028년)
    • 북미
    • 미국
    • 캐나다
    • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 라틴아메리카
    • 브라질
    • 멕시코
    • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아

제11장 기업 프로파일

  • Allscripts Healthcare Solutions
  • McKesson Corporation
  • Orion Health Ltd.
  • Cerner Corporation
  • Phytel Inc.
  • Medecision Inc.
  • GetWellNetwork Inc.
  • YourCareUniverse Inc.
  • Lincor Solutions Ltd.
  • Athenahealth, Inc.
NJH 21.03.19

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of key emerging companies
  • Table 3. Patient Engagement Solutions - Industry Snapshot
  • Table 4. Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 5. Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 6. Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 7. Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 8. Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 9. Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 10. Patient Engagement Solutions Market - Key Market driver's analysis
  • Table 11. Patient Engagement Solutions Market - Key Market restraints analysis
  • Table 12. North America Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 13. North America Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 14. North America Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 15. North America Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 16. North America Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 17. North America Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 18. U.S. Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 19. U.S. Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 20. U.S. Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 21. U.S. Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 22. U.S. Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 23. Canada Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 24. Canada Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 25. Canada Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 26. Canada Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 27. Canada Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 28. Europe Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 29. Europe Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 30. Europe Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 31. Europe Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 32. Europe Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 33. Europe Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 34. U.K. Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 35. U.K. Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 36. U.K. Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 37. U.K. Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 38. U.K. Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 39. Germany Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 40. Germany Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 41. Germany Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 42. Germany Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 43. Germany Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 44. France Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 45. France Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 46. France Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 47. France Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 48. France Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 49. Italy Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 50. Italy Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 51. Italy Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 52. Italy Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 53. Italy Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 54. Spain Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 55. Spain Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 56. Spain Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 57. Spain Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 58. Spain Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 59. Netherlands Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 60. Netherlands Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 61. Netherlands Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 62. Netherlands Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 63. Netherlands Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 64. Sweden Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 65. Sweden Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 66. Sweden Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 67. Sweden Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 68. Sweden Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 69. Russia Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 70. Russia Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 71. Russia Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 72. Russia Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 73. Russia Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 74. Asia Pacific Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 75. Asia Pacific Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 76. Asia Pacific Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 77. Asia Pacific Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 78. Asia Pacific Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 79. Asia Pacific Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 80. Japan Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 81. Japan Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 82. Japan Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 83. Japan Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 84. Japan Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 85. China Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 86. China Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 87. China Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 88. China Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 89. China Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 90. India Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 91. India Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 92. India Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 93. India Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 94. India Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 95. Latin America Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 96. Latin America Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 97. Latin America Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 98. Latin America Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 99. Latin America Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 100. Latin America Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 101. Brazil Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 102. Brazil Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 103. Brazil Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 104. Brazil Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 105. Brazil Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 106. Mexico Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 107. Mexico Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 108. Mexico Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 109. Mexico Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 110. Mexico Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 111. MEA Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 112. MEA Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 113. MEA Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 114. MEA Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 115. MEA Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 116. MEA Patient Engagement Solutions Market, By Region, 2016 to 2028 (USD Million)
  • Table 117. South Africa Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 118. South Africa Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 119. South Africa Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 120. South Africa Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 121. South Africa Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Table 122. Saudi Arabia Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Table 123. Saudi Arabia Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Table 124. Saudi Arabia Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Table 125. Saudi Arabia Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Table 126. Saudi Arabia Patient Engagement Solutions Market, By Therapeutic Area, (USD Million)

List of Figures

  • Fig. 1 Patient Engagement Solutions Market Segmentation
  • Fig. 2 Global Patient Engagement Solutions Market Revenue, 2016 - 2028
  • Fig. 3 Patient Engagement Solutions Market Dynamics
  • Fig. 4 Key Opportunities Prioritized
  • Fig. 5 Patient Engagement Solutions Market Analysis - Porter's
  • Fig. 6 Patient Engagement Solutions Market Analysis - PESTEL Analysis
  • Fig. 7 Global Patient Engagement Solutions Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 8 Global Patient Engagement Solutions Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 9 Global Patient Engagement Solutions Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 10 Global Patient Engagement Solutions Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 11 Global Patient Engagement Solutions Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 12 Delivery Type Market, 2016 to 2028 (USD Million)
  • Fig. 13 Web/Cloud-Based Delivery Market, 2016 to 2028 (USD Million)
  • Fig. 14 On-premise Delivery Market, 2016 to 2028 (USD Million)
  • Fig. 15 Component Market, 2016 to 2028 (USD Million)
  • Fig. 16 Software Market, 2016 to 2028 (USD Million)
  • Fig. 17 Services Market, 2016 to 2028 (USD Million)
  • Fig. 18 Hardware Market, 2016 to 2028 (USD Million)
  • Fig. 19 End-Use Market, 2016 to 2028 (USD Million)
  • Fig. 20 Payers Market, 2016 to 2028 (USD Million)
  • Fig. 21 Providers Market, 2016 to 2028 (USD Million)
  • Fig. 22 Individual users Market, 2016 to 2028 (USD Million)
  • Fig. 23 Application Market, 2016 to 2028 (USD Million)
  • Fig. 24 Social Management Market, 2016 to 2028 (USD Million)
  • Fig. 25 Health Management Market, 2016 to 2028 (USD Million)
  • Fig. 26 Home Healthcare Management Market, 2016 to 2028 (USD Million)
  • Fig. 27 Financial Health Management Market, 2016 to 2028 (USD Million)
  • Fig. 28 Therapeutic Area Market, 2016 to 2028 (USD Million)
  • Fig. 29 Chronic Diseases Market, 2016 to 2028 (USD Million)
  • Fig. 30 Women's Health Market, 2016 to 2028 (USD Million)
  • Fig. 31 Fitness Market, 2016 to 2028 (USD Million)
  • Fig. 32 Mental Health Market, 2016 to 2028 (USD Million)
  • Fig. 33 Others Market, 2016 to 2028 (USD Million)
  • Fig. 34 Global Patient Engagement Solutions Market, By region 2016 to 2028 (USD Million)
  • Fig. 35 North America Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 36 North America Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 37 North America Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 38 North America Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 39 North America Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 40 U.S. Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 41 U.S. Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 42 U.S. Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 43 U.S. Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 44 U.S. Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 45 Canada Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 46 Canada Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 47 Canada Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 48 Canada Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 49 Canada Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 50 Europe Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 51 Europe Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 52 Europe Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 53 Europe Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 54 Europe Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 55 U.K. Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 56 U.K. Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 57 U.K. Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 58 U.K. Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 59 U.K. Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 60 Germany Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 61 Germany Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 62 Germany Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 63 Germany Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 64 Germany nada Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 65 Spain Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 66 Spain Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 67 Spain Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 68 Spain Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 69 Spain Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 70 France Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 71 France Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 72 France Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 73 France Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 74 France Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 75 Italy Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 76 Italy Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 77 Italy Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 78 Italy Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 79 Italy Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 80 Sweden Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 81 Sweden Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 82 Sweden Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 83 Sweden Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 84 Sweden Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 85 Netherlands Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 86 Netherlands Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 87 Netherlands Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 88 Netherlands Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 89 Netherlands Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 90 Russia Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 91 Russia Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 92 Russia Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 93 Russia Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 94 Russia Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 95 APAC Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 96 APAC Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 97 APAC Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 98 APAC Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 99 APAC Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 100 China Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 101 China Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 102 China Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 103 China Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 104 China Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 105 Japan Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 106 Japan Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 107 Japan Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 108 Japan Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 109 Japan Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 110 India Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 111 India Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 112 India Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 113 India Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 114 India Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 115 LATAM Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 116 LATAM Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 117 LATAM Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 118 LATAM Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 119 LATAM Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 120 Mexico Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 121 Mexico Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 122 Mexico Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 123 Mexico Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 124 Mexico Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 125 Brazil Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 126 Brazil Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 127 Brazil Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 128 Brazil Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 129 Brazil Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 130 MEA Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 131 MEA Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 132 MEA Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 133 MEA Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 134 MEA Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 135 South Africa Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 136 South Africa Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 137 South Africa Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 138 South Africa Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 139 South Africa Market, By Therapeutic Area, 2016 to 2028 (USD Million)
  • Fig. 140 Saudi Arabia Market, By Delivery Type, 2016 to 2028 (USD Million)
  • Fig. 141 Saudi Arabia Market, By Component, 2016 to 2028 (USD Million)
  • Fig. 142 Saudi Arabia Market, By End Use, 2016 to 2028 (USD Million)
  • Fig. 143 Saudi Arabia Market, By Application, 2016 to 2028 (USD Million)
  • Fig. 144 Saudi Arabia Market, By Therapeutic Area, 2016 to 2028 (USD Million)

Patient Engagement Solutions Market Growth & Trends

The global patient engagement solutions market size is expected to reach USD 70.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 21.4% from 2021 to 2028. The market is expected to register exponential growth due to the adoption of m-health; increasing prevalence of chronic conditions such as diabetes, asthma, and arthritis; improved healthcare services; enhanced patient education; patient data tracking; and diagnostic treatment.

In January 2021, the Biden-Harris administration opened a "Special Enrollment Period". Under this action, Americans to sign up for health coverage and roll back attacks on the Medicaid, Affordable Care Act, and access to reproductive health care. Hence, such orders meet the healthcare requirements formed by the COVID-19 outbreak, it will protect access to reproductive health care, and make health care system easier and more unbiassed. Such initiatives are anticipated to drive the demand for these services over the forecast period.

As healthcare providers were battling with the constant upsurge in numerous cases, patients were looking to digital technologies for the support which promoted the adoption of a product. The outbreak has resulted in the introduction of multiple COVID-19- related features patient engagement solutions by various players. The growing number of smartphone users around the globe expedited the adoption of mHealth across the sector both from providers and consumers which in turn, has augmented the dependability of patients on mHealth apps.

Moreover, in March 2019, the American Medical Association entered a collaboration with Patient Point with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using Patient Point technology, approximately 6,500 practicing doctors across U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to drive market growth over the forecast period.

The necessity of social distancing resulted in the demand for remote patient monitoring solutions along with the prerequisite for the precise and timely exchange of patient wellbeing records. The pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants had come up with COVID-19- related features into their existing patient engagement solutions. For instance, in 2020, Orion Health has established the first complete pandemic outbreak monitoring platform to control the spread of the coronavirus. Hence, it led to the adoption of the solutions.

Patient Engagement Solutions Market Report Highlights

The web-based/cloud-based emerged as the largest delivery type segment in 2020 and accounted for over 80.0% revenue share as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and enable remote access

The software segment dominated the market in 2020, owing to continuous development in patient engagement solutions along with its increasing applications in consulting, education, and implementation. Software solutions are easy to install and use, enable quick access to specific drug information, and enable healthcare providers to digitally upload prescriptions

Rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for these services in the coming years

The chronic diseases segment dominated the market in 2020 owing to the associated benefits of these solutions in chronic disease management. These solutions help patients connect with their healthcare providers from remote locations, thereby enabling streamlined flow of information, patient feedback, and other health-related data

North America dominated the market in 2020 owing to increased adoption of m-health and Electronic Health Record (EHR) and growing investments in patient engagement software by major companies

Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
    • 1.10.3 Market Definitions

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Outlook
  • 2.4 Pateint Engagement Solutions Market Summary, 2020

Chapter 3 Patient Engagement Solutions Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping by Technology, 2020
  • 3.3 User Perspective Analysis
    • 3.3.1 Buyer's Preference Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 Regulatory Framework
    • 3.4.1 Regulatory Landscape
  • 3.5 Technology Overview
    • 3.5.1 Patient engagement solutions: Adoption rate of changing technology
    • 3.5.2 Timeline with major technology changes
  • 3.6 Market Dynamics
    • 3.6.1 Market Driver Analysis
    • 3.6.2 Market Restraints Analysis
    • 3.6.3 Industry Challenges
  • 3.7 Industry Analysis - Porter's
  • 3.8 Patient Engagement Solutions - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
  • 3.9 Major Deals & Strategic Alliances Analysis
    • 3.9.1 Joint Ventures
    • 3.9.2 Mergers & Acquisitions
    • 3.9.3 Licensing & Partnership
    • 3.9.4 Technology Collaborations
    • 3.9.5 Strategic Divestments
  • 3.10 Market Entry Strategies

Chapter 4 Patient Engagement Solutions Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
  • 4.3 Key company market share analysis, 2020
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.4.2 Market Differentiators
    • 4.4.3 Synergy Analysis: Major Deals & Strategic Alliances
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies' /technology disruptors/innovators
    • 4.5.2 Regional network map
  • 4.6 Key customers
    • 4.6.1 List of key buyers
  • 4.7 Potential Target Audience

Chapter 5 Patient Engagement Solutions Market: Delivery Type Analysis

  • 5.1 Delivery Type Business Analysis
    • 5.1.1 Web/Cloud-Based
      • 5.1.1.1 Web/cloud-based market estimates and forecasts, 2016 - 2028 (USD Million)
    • 5.1.2 On-Premise
      • 5.1.2.1 On-premise market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 6 Patient Engagement Solutions Market: Component

  • 6.1 Component Analysis
    • 6.1.1 Software
      • 6.1.1.1 Software market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.1.2 Standalone software
      • 6.1.1.2.1 Standalone software market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.1.3 Integrated
      • 6.1.1.3.1 Integrated market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.1.2 Services
      • 6.1.2.1 Services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.2 Consulting Services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.3 Implementation services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.4 Education services market estimates and forecasts, 2016 - 2028 (USD Million)
      • 6.1.2.5 Others services market estimates and forecasts, 2016 - 2028 (USD Million)
    • 6.1.2 Hardware
      • 6.1.2.1 Hardware market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 7 Patient Engagement Solutions Market: End-use

  • 7.1 End-use Analysis
    • 7.1.1 Payers
      • 7.1.1.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.1.2 Providers
      • 7.1.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 7.1.3 Individual Users
      • 7.1.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 8 Patient Engagement Solutions Market: Application

  • 8.1 Application Analysis
    • 8.1.1 Social Management
      • 8.1.1.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.1.2 Health Management
      • 8.1.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.1.3 Home Healthcare Management
      • 8.1.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 8.1.4 Financial Health Management
      • 8.1.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 9 Patient Engagement Solutions Market: Therapeutic Area

  • 9.1 Application Analysis
    • 9.1.1 Chronic Diseases
      • 9.1.1.1 Chronic diseases market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.2 Obesity
      • 9.1.1.2.1 Obesity market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.3 Diabetes
      • 9.1.1.3.1 Diabetes market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.4 Cardiovascular
      • 9.1.1.4.1 Cardiovascular market estimates and forecasts, 2016 - 2028 (USD Million)
      • 9.1.1.5 Others
      • 9.1.1.5.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.2 Fitness
      • 9.1.2.1 Fitness market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.3 Women's Health
      • 9.1.3.1 Women's Health market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.4 Mental Health
      • 9.1.4.1 Mental Health market estimates and forecasts, 2016 - 2028 (USD Million)
    • 9.1.5 Others
      • 9.1.5.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 10 Patient Engagement Solutions: Regional Market Analysis, By Application, Technology, and End Use 2016 - 2028 (USD Million)

  • 10.1 Regional Market Share Analysis, 2020 & 2028
  • 10.2 Regional Market Dashboard
  • 10.3 Regional Market Snapshot
  • 10.4 Market Size, & Forecasts and Trend Analysis, 2020 to 2028
    • 10.4.1 North America
    • 10.4.2 Market estimates and segment forecasts, 2016 - 2028 (USD Million)
    • 10.4.3 U.S.
      • 10.4.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.4 Canada
      • 10.4.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.5 Europe
    • 10.4.6 Market estimates And Forecasts By Countries, 2016 - 2028 (USD Million)
    • 10.4.7 U.K.
      • 10.4.7.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.8 Germany
      • 10.4.8.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.9 France
      • 10.4.9.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.10 Italy
      • 10.4.10.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.11 Spain
      • 10.4.11.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.12 Netherlands
      • 10.4.12.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.13 Sweden
      • 10.4.13.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.13 Russia
      • 10.4.13.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.14 Asia Pacific
    • 10.4.15 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.16 Japan
      • 10.4.16.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.17 China
      • 10.4.17.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.18 India
      • 10.4.18.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.19 Latin America
    • 10.4.20 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.21 Brazil
      • 10.4.21.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.22 Mexico
      • 10.4.22.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.23 MEA
    • 10.4.24 Market estimates and forecasts by countries, 2016 - 2028 (USD Million)
    • 10.4.25 South Africa
      • 10.4.25.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
    • 10.4.26 Saudi Arabia
      • 10.4.26.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 11 Company Profiles

  • 11.1 Allscripts Healthcare Solutions
    • 11.1.1 Company Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Benchmarking
    • 11.1.4 Strategic Initiatives
  • 11.2 McKesson Corporation
    • 11.2.1 Company Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Benchmarking
    • 11.2.4 Strategic Initiatives
  • 11.3 Orion Health Ltd.
    • 11.3.1 Company Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Benchmarking
    • 11.3.4 Strategic Initiatives
  • 11.4 Cerner Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Benchmarking
    • 11.4.4 Strategic Initiatives
  • 11.5 Phytel Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Benchmarking
    • 11.5.4 Strategic Initiatives
  • 11.6 Medecision Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Benchmarking
    • 11.6.4 Strategic Initiatives
  • 11.7 GetWellNetwork Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Benchmarking
    • 11.7.4 Strategic Initiatives
  • 11.8 YourCareUniverse Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Benchmarking
    • 11.8.4 Strategic Initiatives
  • 11.9 Lincor Solutions Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Benchmarking
    • 11.9.4 Strategic Initiatives
  • 11.10 Athenahealth, Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Benchmarking
    • 11.10.4 Strategic Initiatives
Back to Top
전화 문의
F A Q